Recent Finacing
Recent Raise
Immunis.AI develops the Intelligentia immunogenomic liquid-biopsy platform that analyzes immune signals, RNA sequencing, and machine learning on blood samples to detect and grade early-stage prostate and other cancers.
Focus Areas
Recent Investors
Funding round
Investor